Pelthos Therapeutics Growth Metrics (2024-2025) | PTHS

Growth Metrics Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Growth Ratios
Assets Growth (1y) (Quarter) 1,320.26%-77.40%-68.40%5,808.39%9,424.98%
Assets (QoQ) (Quarter) 4,082.51%-35.42%-17.81%-36.02%-33.44%-9.69%15,265.25%3.14%
Cash & Equivalents Growth (1y) (Quarter) 434.38%-96.52%-97.54%2,668.62%3,403.51%
Cash & Equivalents (QoQ) (Quarter) 3,827.32%-36.21%-78.67%0.00%-74.40%-54.94%23,902.91%26.54%
Cash from Operations Growth (1y) (Quarter) 68.27%84.85%-8,487.18%-833.13%
Cash from Operations (QoQ) (Quarter) -48.22%93.98%-277.06%5.65%29.26%-3,312.48%59.03%
EBITDA Margin (QoQ) (Quarter) 13,469.00
EBIT Growth (1y) (Quarter) 5.17%-83.12%-649.73%-558.06%
EBIT Margin (QoQ) (Quarter) 13,469.00
EBIT (QoQ) (Quarter) 8.78%-16.15%10.98%-0.55%-76.14%-375.54%21.87%
EBT Growth (1y) (Quarter) 23.21%-94.68%-885.43%-1,384.22%
EBT Margin (QoQ) (Quarter) 5,230.00
EBT (QoQ) (Quarter) 30.86%4.32%-13.63%-2.16%-75.29%-384.29%-71.14%
Enterprise Value Growth (1y) (Quarter) -434.38%96.52%97.54%-2,678.36%-3,413.26%
Enterprise Value (QoQ) (Quarter) -3,827.32%36.21%78.67%0.00%74.40%54.94%-23,987.41%-26.45%
EPS (Basic) Growth (1y) (Quarter) 41.62%-1,675.17%-1,728.95%12.46%
EPS (Basic) (QoQ) (Quarter) 43.64%6.45%-4,437.93%97.56%-1,613.86%3.62%-117.20%
EPS (Weighted Average and Diluted) Growth (1y) (Quarter) 41.22%-59.03%-69.61%-233.44%
EPS (Weighted Average and Diluted) (QoQ) (Quarter) -519.87%7.64%-10.49%90.71%-1,576.98%1.50%-117.20%
FCF Margin (QoQ) (Quarter) 16,814.00
Free Cash Flow Growth (1y) (Quarter) 68.27%84.85%-8,487.18%-833.13%
Free Cash Flow (QoQ) (Quarter) -48.22%93.98%-277.06%5.65%29.26%-3,312.48%59.03%
Gross Margin (QoQ) (Quarter) 2,114.00
Gross Profit (QoQ) (Quarter) 191.34%
Interest Coverage Ratio Growth (1y) (Quarter) 78.28%45.91%
Interest Coverage Ratio (QoQ) (Quarter) 67.85%-5,879.67%-12.95%99.00%19.96%
Net Cash Flow Growth (1y) (Quarter) -110.40%94.72%1,094.45%608.09%
Net Cash Flow (QoQ) (Quarter) -137.16%15.78%35.46%48.50%81.12%15,947.63%-67.03%
Net Income Growth (1y) (Quarter) 23.21%-94.68%-857.99%-1,024.82%
Net Income (QoQ) (Quarter) 30.86%4.32%-13.63%-2.16%-75.29%-370.81%-33.42%
Net Income towards Common Stockholders Growth (1y) (Quarter) 23.21%-94.68%-857.99%-1,024.82%
Net Income towards Common Stockholders (QoQ) (Quarter) 30.86%4.32%-13.63%-2.16%-75.29%-370.81%-33.42%
Net Margin (QoQ) (Quarter) 8,797.00
Operating Income Growth (1y) (Quarter) 5.17%-83.12%-649.73%-558.06%
Operating Income (QoQ) (Quarter) 8.78%-16.15%10.98%-0.55%-76.14%-375.54%21.87%
Operating Margin (QoQ) (Quarter) 13,469.00
Profit After Tax Growth (1y) (Quarter) 23.21%-94.68%-857.99%-1,024.82%
Profit After Tax (QoQ) (Quarter) 30.86%4.32%-13.63%-2.16%-75.29%-370.81%-33.42%
Property, Plant & Equipment (Net) (QoQ) (Quarter) -5.78%
Return on Assets Growth (1y) (Quarter) 2.004.00
Return on Assets (QoQ) (Quarter) -2.00-2.00-4.0010.000.00
Return on Capital Employed Growth (1y) (Quarter) -35680.00
Return on Capital Employed (QoQ) (Quarter) -13681.00-4977.00-19582.002,560.00
Return on Equity Growth (1y) (Quarter) -8.00-5.00
Return on Equity (QoQ) (Quarter) -4.00-2.000.00-3.000.00
Return on Sales (QoQ) (Quarter) 1.00
Revenue (QoQ) (Quarter) 122.81%
Share-based Compensation Growth (1y) (Quarter) 66.07%-9.91%543.48%239.43%
Share-based Compensation (QoQ) (Quarter) 56.89%-4.79%21.28%-8.33%-14.89%580.07%-36.02%
Shareholder's Equity Growth (1y) (Quarter) 57.89%-471.33%-3,429.35%4,179.34%1,532.61%
Shareholder's Equity (QoQ) (Quarter) 117.53%-116.28%-676.09%-90.06%-54.61%-54.77%997.03%-33.25%
Tax Rate (QoQ) (Quarter) 2,143.00
Total Debt Growth (1y) (Quarter) 191.43%0.00%
Total Debt (QoQ) (Quarter) 0.00%1,557.72%-93.97%0.00%